Session Information
IBMS Davos Workshops: Bone Biology & Therapeutics
Click here to go to the previous page
RANK Ligand Inhibition in Cancer Patients: Current Status - part of a Satellite Symposium sponsored by Amgen, Inc.
Track
:
Satellite Symposium - The Role of the RANK/RANK Ligand/OPG Pathway in Pathological Bone Loss sponsored by Amgen, Inc.
Program Code:
460
Date:
Thursday, March 13, 2008
Time:
4:30 PM to 5:00 PM
EST
Location:
Auditorium
SPEAKER
:
Jean-Jacques Body
Audio Synchronized to PowerPoint
